TAU

2-AMINOETHANESULFONIC ACID

Created: 2001-12-05
Last modified:  2024-09-27

Help

Find related ligands:

Chemical Details

Formal Charge0
Atom Count14
Chiral Atom Count0
Bond Count13
Aromatic Bond Count0
2D diagram of TAU
Toggle HydrogenToggle Labels

Chemical Component Summary

Name2-AMINOETHANESULFONIC ACID
Systematic Name (OpenEye OEToolkits)2-aminoethanesulfonic acid
FormulaC2 H7 N O3 S
Molecular Weight125.147
TypeNON-POLYMER

Chemical Descriptors

TypeProgram Version Descriptor
SMILESACDLabs10.04O=S(=O)(O)CCN
SMILESCACTVS3.341NCC[S](O)(=O)=O
SMILESOpenEye OEToolkits1.5.0C(CS(=O)(=O)O)N
Canonical SMILESCACTVS3.341 NCC[S](O)(=O)=O
Canonical SMILESOpenEye OEToolkits1.5.0 C(CS(=O)(=O)O)N
InChIInChI1.03 InChI=1S/C2H7NO3S/c3-1-2-7(4,5)6/h1-3H2,(H,4,5,6)
InChIKeyInChI1.03 XOAAWQZATWQOTB-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank IDDB01956 
NameTaurine
Groups
  • approved
  • nutraceutical
DescriptionTaurine, whose chemical name is 2-aminoethanesulfonic acid, is one of the most abundant amino acids in several organs. It plays important role in essential biological processes.[A31396] This conditional amino acid can be either be manufactured by the body or obtained in the diet mainly by the consumption of fish and meat.[L1058] The supplements containing taurine were FDA approved by 1984 and they are hypertonic injections composed by cristalline amino acids.[FDA label]
Synonyms
  • Taurine
  • Taurineold
  • Aminoethylsulfonic acid
Brand Names
  • Ginsamin Energy
  • Essepna
  • Aminosyn-PF
  • Aminosyn-PF 10%
  • Lingtea
IndicationThe use of diet supplements containing taurine is indicated for the nutritional support of infants and young pediatric patients requiring total parenteral nutrition via central or peripheral routes. The usage of diet supplements containing taurine prevents nitrogen and weight loss or to treat negative nitrogen balance in pediatric patients where the alimentary tract cannot be done through oral, gastrostomy or jejunostomy administration, there is impaired gastrointestinal absorption or protein requirements are substantially increased.[FDA label]
Categories
  • Alkanes
  • Alkanesulfonic Acids
  • Amino Acids
  • Amino Acids, Peptides, and Proteins
  • Hydrocarbons, Acyclic
CAS number107-35-7

Drug Targets

NameTarget SequencePharmacological ActionActions
Glutamate receptor ionotropic, NMDA 2BMKPRAECCSPKFWLVLAVLAVSGSRARSQKSPPSIGIAVILVGTSDEVAI...unknowninhibitor
Glycine receptor subunit alpha-2MNRQLVNILTALFAFFLETNHFRTAFCKDHDSRSGKQPSQTLSPSDFLDK...unknownagonist
Glycine receptor subunit alpha-3MAHVRHFRTLVSGFYFWEAALLLSLVATKETDSARSRSAPMSPSDFLDKL...unknownagonist
GABA(A) ReceptorMRKSPGLSDCLWAWILLLSTLTGRSYGQPSLQDELKDNTTVFTRILDRLL...unknownagonist
Gamma-aminobutyric acid type B receptor subunit 1MLLLLLLAPLFLRPPGAGGAQTPNATSEGCQIIHPPWEGGIRYRGLTRDQ...unknownagonist
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
PubChem 4068592, 1123
ChEMBL CHEMBL239243
ChEBI CHEBI:15891, CHEBI:507393
CCDC/CSD ODIDUC